Novel Drug Combination for Treating Hypertension and Dyslipidemia

"To Study Effectiveness of Novel Drug Combination Containing Atenolol and Atorvastatin for Simultaneously Treating Hypertension and Dyslipidemia" Hypertension and dyslipidemia are two of the most commonly co-occurring cardiovascular risk factors. In a recent study utilizing data from various clinical studies, it was estimated that almost 15% of adults have both hypertension and dyslipidemia. It was also shown that more than 64% of patients with hypertension also have dyslipidemia; conversely, approximately 47% of patients with dyslipidemia have hypertension. These two risk factors together cause an increase in coronary heart disease-related events that is more than simply additive for anticipated event rates with each disease. This study was undertaken to find out the physical and pharmacological compatibility of atenolol and atorvastatin so that both drug can be incorporated in one doses form like tablet or capsule. Because of such study patient adherence to therapy will be increased and definitely lower the cost of treatment.

Autorentext
Dr. Shivshankar D. Mhaske has completed his Ph.D from Pacific Academy of Higher Education and Research, University Udaipur and M. Pharmacy Pharmacology from SGBAU, Amravati. He has published various research papers in national/international journals. Prof. MAHESH B. NARKHEDE received M in Pharmacology. Prof. Sumedh N. Moharil obtanined M in Pharm.